Finance

Lists
Why is 603193 up 8,48%?
Dive Deeper
603193:SHA
Runben Biotechnology Co Ltd
CN¥20,21
+8,48%
(+1,58) 1D
16 Okt., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603193...
Open
CN¥18,86
High
CN¥20,49
Low
CN¥18,69
Mkt. cap
7,54 mjd
Avg. vol.
2,44 m
Volume
10,50 m
Dividend
2,67%
Quarterly dividend
CN¥0,14
Ex-dividend date
21 Sep. 2026
P/E ratio
23,23
52-wk high
CN¥28,23
52-wk low
CN¥17,77
EPS
CN¥0,87
No. of employees
1 k
Open
CN¥18,86
High
CN¥20,49
Low
CN¥18,69
Mkt. cap
7,54 mjd
Avg. vol.
2,44 m
Volume
10,50 m
Dividend
2,67%
Quarterly dividend
CN¥0,14
Ex-dividend date
21 Sep. 2026
P/E ratio
23,23
52-wk high
CN¥28,23
52-wk low
CN¥17,77
EPS
CN¥0,87
No. of employees
1 k
News stories
From web sources and news partners
About Runben Biotechnology Co Ltd
CEO-
Employees1,02 k
Founded1993
Headquarters-
SectorPersonal care products
Websiterunben.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
342,41 m
307,27 m
267,09 m
786,78 m
Cost of goods sold
138,21 m
130,24 m
109,25 m
310,05 m
Cost of revenue
138,21 m
130,24 m
109,25 m
310,05 m
Research and development expenses
8,74 m
12,46 m
8,38 m
8,40 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107,83 m
126,19 m
95,26 m
263,67 m
Operating expense
116,04 m
142,36 m
106,00 m
282,96 m
Total operating expenses
254,26 m
272,60 m
215,25 m
593,00 m
Operating income
88,16 m
34,67 m
51,84 m
193,77 m
Other non operating income
-82,64 k
96,83 k
-78,74 k
-245,68 k
EBT including unusual items
93,42 m
48,69 m
57,21 m
202,39 m
EBT excluding unusual items
95,58 m
43,53 m
56,27 m
196,37 m
Income tax expense
14,89 m
234,06 k
4,57 m
29,94 m
Effective tax rate
15,94%
0,48%
7,99%
14,79%
Other operating expenses
1,92 m
4,47 m
2,11 m
7,18 m
Net income
78,52 m
48,45 m
52,64 m
172,46 m
Net profit margin
22,93%
15,77%
19,71%
21,92%
Earnings per share
-
-
-
-
Interest and investment income
7,50 m
8,73 m
4,52 m
2,91 m
Interest expense
-18,73 k
-15,50 k
-12,23 k
-8,94 k
Net interest expenses
7,48 m
8,71 m
4,51 m
2,90 m
Depreciation and amortization charges
-
-
-
-
EBITDA
93,06 m
39,81 m
56,98 m
199,34 m
Gain or loss from assets sale
80,15 k
-80,39 k
-
2,02 k
AI content may include mistakes. Learn more
Google-programme